Literature DB >> 9598934

Comparison of tests for antibody to hepatitis E virus.

T M Ghabrah1, S Tsarev, P O Yarbough, S U Emerson, G T Strickland, R H Purcell.   

Abstract

The results of serologic tests for hepatitis E virus have varied widely from laboratory to laboratory, making interpretation of seroepidemiologic studies difficult. The present study compares serologic results with different antigens and tests developed in two laboratories for their ability to diagnose hepatitis E and measure antibody prevalence in a high risk population in Saudi Arabia. The results confirm that tests based upon open reading frame (ORF) 3 of HEV are of limited value for seroepidemiologic studies, whereas ORF2-based antigens have broad utility and yield data that are reproducible in more than one laboratory.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9598934

Source DB:  PubMed          Journal:  J Med Virol        ISSN： 0146-6615            Impact factor:   2.327


  23 in total

1.  Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies.

Authors:  M A Riddell; F Li; D A Anderson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Genetic characteristics and pathogenicity of human hepatitis E virus in Nanjing, China.

Authors:  Jia-Bao Geng; Mao-Rong Wang; Ling Wang; Jie Wang; Zhi-Guo Yang; Yan Cheng; Fei Qiao; Min Wang
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

3.  Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay.

Authors:  C Yu; R E Engle; J P Bryan; S U Emerson; R H Purcell
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

4.  Quantitation of immunoglobulin to hepatitis E virus by enzyme immunoassay.

Authors:  Bruce L Innis; Jitvimol Seriwatana; Robin A Robinson; Mrigendra P Shrestha; Patrice O Yarbough; Charles F Longer; Robert M Scott; David W Vaughn; Khin Saw Aye Myint
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

5.  Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in The Netherlands.

Authors:  M Bouwknegt; B Engel; M M P T Herremans; M A Widdowson; H C Worm; M P G Koopmans; K Frankena; A M de Roda Husman; M C M De Jong; W H M Van Der Poel
Journal:  Epidemiol Infect       Date:  2007-06-20       Impact factor: 2.451

Review 6.  Hepatitis E: an overview and recent advances in vaccine research.

Authors:  Ling Wang; Hui Zhuang
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

7.  Clinical and epidemiological relevance of quantitating hepatitis E virus-specific immunoglobulin M.

Authors:  Jitvimol Seriwatana; Mrigendra P Shrestha; Robert M Scott; Sergei A Tsarev; David W Vaughn; Khin Saw Aye Myint; Bruce L Innis
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

8.  Synthetic rabbit-human antibody conjugate as a control in immunoassays for immunoglobulin M specific to hepatitis E virus.

Authors:  Kuo Zhang; Lunan Wang; Min Liu; Rui Zhang; Jinming Li
Journal:  Virol J       Date:  2010-05-20       Impact factor: 4.099

9.  Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark.

Authors:  Peer B Christensen; Ronald E Engle; Charlotte Hjort; Keld M Homburg; Werner Vach; Jørgen Georgsen; Robert H Purcell
Journal:  Clin Infect Dis       Date:  2008-10-15       Impact factor: 9.079

Review 10.  Hepatitis E vaccines: progress and prospects.

Authors:  Harald Claus Worm; Gerhard Wirnsberger
Journal:  Drugs       Date:  2004       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.